Literature DB >> 30268565

Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes.

Zobair M Younossi1, Maria Stepanova2, Issah Younossi2, Calvin Q Pan3, Harry L A Janssen4, George Papatheodoridis5, Fatema Nader2.   

Abstract

Worldwide, viral hepatitis remains the most common cause of chronic liver disease.1 In this context, hepatitis B virus (HBV) infection and its complications are responsible for a tremendous clinical burden related to cirrhosis and hepatocellular carcinoma.1 In contrast, long-term HBV suppression can improve hepatic fibrosis and clinical outcomes.2.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID： 30268565     DOI： 10.1016/j.cgh.2018.09.041

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  5 in total

1.  Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years.

Authors:  Pallavi Surana; Devika Kapuria; Carly Broadwell; Elizabeth C Wright; Varun Takyar; David E Kleiner; Marc G Ghany; Gil Ben-Yakov; Theo Heller; T Jake Liang; Christopher Koh
Journal:  Antiviral Res       Date:  2019-05-21       Impact factor: 5.970

2.  Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case-control study.

Authors:  Kuo-Yu Fu; Vivian Chia-Rong Hsieh; Meng-Lun Hsieh; Jou-An Chen
Journal:  BMJ Open       Date:  2022-06-13       Impact factor: 3.006

3.  Health-Related Quality of Life and Frailty in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Life (Basel)       Date:  2020-05-24

4.  Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases.

Authors:  Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Naoto Ikeda; Nobuhiro Aizawa; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Diagnostics (Basel)       Date:  2020-04-20

5.  Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.

Authors:  Maria Buti; Maria Stepanova; Adriana Palom; Mar Riveiro-Barciela; Fatema Nader; Luisa Roade; Rafael Esteban; Zobair Younossi
Journal:  JHEP Rep       Date:  2021-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.